0002069952-25-000001.txt : 20250620 0002069952-25-000001.hdr.sgml : 20250620 20250620095445 ACCESSION NUMBER: 0002069952-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250620 DATE AS OF CHANGE: 20250620 EFFECTIVENESS DATE: 20250620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lumina Pharmaceuticals Inc. CENTRAL INDEX KEY: 0002069952 ORGANIZATION NAME: EIN: 334744166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-549406 FILM NUMBER: 251059407 BUSINESS ADDRESS: STREET 1: 1 HUNTINGTON AVE. #1802 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-420-1150 MAIL ADDRESS: STREET 1: 1 HUNTINGTON AVE. #1802 CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0002069952 Lumina Pharmaceuticals Inc. 1 HUNTINGTON AVE. #1802 BOSTON MA MASSACHUSETTS 02116 617-420-1150 DELAWARE None None Corporation true 2025 Alma Gregory Sorensen 1 Huntington Ave. #1802 Boston MA MASSACHUSETTS 02116 Executive Officer Director Peter Caravan 1 Huntington Ave. #1802 Boston MA MASSACHUSETTS 02116 Director Cara Ferreira 1 Huntington Ave. #1802 Boston MA MASSACHUSETTS 02116 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2025-05-07 false true Simple Agreement for Future Equity false 25000 2000000 2000000 0 false 2 0 true 0 true 0 true false Lumina Pharmaceuticals Inc. /s/ A. Gregory Sorensen A. Gregory Sorensen President 2025-06-20